Citation & Authors
Am J Transplant. 2025;25(9):1954-1964.
ABSTRACT · RESEARCH SUMMARY
Research summary
The TriNetX study matched 1,410 pairs of new users with kidney transplantation and diabetes. Compared with DPP-4 inhibitors, SGLT2 inhibitors were associated with lower risks of dialysis (HR 0.694) and all-cause mortality (0.687). Post-transplant infection, rejection, and hospitalization did not differ significantly. These findings suggest possible kidney and survival benefits, but stronger causal evidence is needed.
Key points based on the public abstract; this is a reading guide, not a full abstract translation.Read original abstract ↗
